Invesco Ltd.

Position in URGN — UroGen Pharma Ltd.

CIK 914208 Atlanta, GA

Position in URGN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$954,112

+$449,237 QoQ

Shares Held

25,927

-7.7% QoQ

Ownership

0.053%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#79

of 190 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 0% Shared 96% None 4%

Healthcare · as of Jun 30, 2026

Invesco Ltd. holds $14,420,023,301 across 296 Biotechnology names. URGN ranks #152 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	8,043,052	$3,995,225,212
2	REGN	Regeneron Pharmaceuticals, Inc.	3,940,665	$2,457,162,245
3	ALNY	Alnylam Pharmaceuticals, Inc.	3,754,318	$1,130,162,341
4	INCY	Incyte Corp	4,080,461	$462,561,050
5	ARGX	Argenx SE	443,990	$411,920,598
6	AXSM	Axsome Therapeutics, Inc.	1,671,684	$409,178,086
7	MRNA	Moderna, Inc.	5,780,299	$404,794,337
8	LGND	Ligand Pharmaceuticals Inc	1,201,644	$379,827,645

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$954,112	25,927	-7.7%	Shares	Defined	2026-08-14
2026-03-31	$504,875	28,080	+3.7%	Shares	Defined	2026-05-12
2025-12-31	$633,885	27,066	+21.1%	Shares	Defined	2026-02-19
2025-09-30	$445,981	22,355	+75.5%	Shares	Defined	2025-11-13
2025-06-30	$174,550	12,741	+0.2%	Shares	Defined	2025-08-13
2025-03-31	$140,571	12,710	-5.5%	Shares	Defined	2025-05-12
2024-12-31	$143,304	13,456	+4.9%	Shares	Defined	2025-02-13
2024-09-30	$162,838	12,822	+9.9%	Shares	Defined	2024-11-12
2024-06-30	$195,705	11,663	+8.4%	Shares	Defined	2024-08-13
2024-03-31	$161,370	10,758	+6.5%	Shares	Defined	2024-05-14
2023-12-31	$151,530	10,102	+0.5%	Shares	Defined	2024-02-13
2023-09-30	$140,870	10,055	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.